News
03-23-2012, 07:30 AM
Preoperative treatment with aromatase inhibitors increases the likelihood that postmenopausal women with estrogen receptor-positive breast cancer will be able to have breast-conserving surgery rather than a mastectomy, according to the results of a national clinical trial presented today at the Society of Surgical Oncology annual meeting in Orlando, Fla.
More... (http://www.news-medical.net/news/20120323/Treatment-with-aromatase-inhibitors-enables-some-women-to-have-lumpectomy.aspx)
More... (http://www.news-medical.net/news/20120323/Treatment-with-aromatase-inhibitors-enables-some-women-to-have-lumpectomy.aspx)